Published in Lancet on May 17, 2012
HDL cholesterol efflux capacity and incident cardiovascular events. N Engl J Med (2014) 8.61
Discovery and refinement of loci associated with lipid levels. Nat Genet (2013) 7.86
An atlas of genetic correlations across human diseases and traits. Nat Genet (2015) 3.90
Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease. N Engl J Med (2016) 3.88
Pleiotropy in complex traits: challenges and strategies. Nat Rev Genet (2013) 3.65
Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks. Arterioscler Thromb Vasc Biol (2013) 3.07
High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy. Circulation (2013) 3.03
Interpreting noncoding genetic variation in complex traits and human disease. Nat Biotechnol (2012) 3.01
Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet (2013) 2.92
Meta-analysis methods for genome-wide association studies and beyond. Nat Rev Genet (2013) 2.58
Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study. PLoS Med (2015) 2.40
Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks. Am J Hum Genet (2014) 2.33
The not-so-simple HDL story: Is it time to revise the HDL cholesterol hypothesis? Nat Med (2012) 2.31
Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study. Lancet Diabetes Endocrinol (2015) 2.23
Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects. Am J Epidemiol (2015) 2.14
Use of allele scores as instrumental variables for Mendelian randomization. Int J Epidemiol (2013) 2.06
Instrumental variable methods for causal inference. Stat Med (2014) 1.90
Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease. Science (2016) 1.90
Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study. Arterioscler Thromb Vasc Biol (2014) 1.87
Genetically low vitamin D concentrations and increased mortality: Mendelian randomisation analysis in three large cohorts. BMJ (2014) 1.83
Increased burden of cardiovascular disease in carriers of APOL1 genetic variants. Circ Res (2013) 1.82
Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease. Nat Genet (2016) 1.71
High-density lipoprotein function, dysfunction, and reverse cholesterol transport. Arterioscler Thromb Vasc Biol (2012) 1.70
Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice. Arterioscler Thromb Vasc Biol (2014) 1.66
Mild renal dysfunction and metabolites tied to low HDL cholesterol are associated with monocytosis and atherosclerosis. Circulation (2013) 1.65
Quantification of HDL particle concentration by calibrated ion mobility analysis. Clin Chem (2014) 1.65
Liver ABCA1 deletion in LDLrKO mice does not impair macrophage reverse cholesterol transport or exacerbate atherogenesis. Arterioscler Thromb Vasc Biol (2013) 1.54
Genetic Architecture of Atherosclerosis in Mice: A Systems Genetics Analysis of Common Inbred Strains. PLoS Genet (2015) 1.52
Mendelian randomization of blood lipids for coronary heart disease. Eur Heart J (2014) 1.51
MRI-measured regression of carotid atherosclerosis induced by statins with and without niacin in a randomised controlled trial: the NIA plaque study. Heart (2013) 1.50
Biochemistry and pathophysiology of intravascular and intracellular lipolysis. Genes Dev (2013) 1.49
Causal Assessment of Serum Urate Levels in Cardiometabolic Diseases Through a Mendelian Randomization Study. J Am Coll Cardiol (2016) 1.46
Genetic variants primarily associated with type 2 diabetes are related to coronary artery disease risk. Atherosclerosis (2015) 1.46
Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk. J Lipid Res (2012) 1.46
Retracted The improvement of large High-Density Lipoprotein (HDL) particle levels, and presumably HDL metabolism, depend on effects of low-carbohydrate diet and weight loss. EXCLI J (2016) 1.44
Surface Density-Induced Pleating of a Lipid Monolayer Drives Nascent High-Density Lipoprotein Assembly. Structure (2015) 1.43
Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease. Hum Mol Genet (2012) 1.43
The TMAO-Generating Enzyme Flavin Monooxygenase 3 Is a Central Regulator of Cholesterol Balance. Cell Rep (2015) 1.40
Effect of Insulin Resistance on Monounsaturated Fatty Acid Levels: A Multi-cohort Non-targeted Metabolomics and Mendelian Randomization Study. PLoS Genet (2016) 1.38
Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet Epidemiol (2016) 1.35
Cardiovascular protection by ApoE and ApoE-HDL linked to suppression of ECM gene expression and arterial stiffening. Cell Rep (2012) 1.34
An abundant dysfunctional apolipoprotein A1 in human atheroma. Nat Med (2014) 1.33
Detection and interpretation of shared genetic influences on 42 human traits. Nat Genet (2016) 1.32
Variation in APOL1 Contributes to Ancestry-Level Differences in HDLc-Kidney Function Association. Int J Nephrol (2012) 1.31
Cardioprotective functions of HDLs. J Lipid Res (2013) 1.29
Genomic study in Mexicans identifies a new locus for triglycerides and refines European lipid loci. J Med Genet (2013) 1.26
Insulin resistance in type 1 diabetes: what is 'double diabetes' and what are the risks? Diabetologia (2013) 1.26
The cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effects. J Biol Chem (2013) 1.22
Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm. Nat Rev Rheumatol (2013) 1.20
Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis. Circulation (2013) 1.20
Residual macrovascular risk in 2013: what have we learned? Cardiovasc Diabetol (2014) 1.20
Novel biological functions of high-density lipoprotein cholesterol. Circ Res (2012) 1.19
A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans. Nat Commun (2014) 1.18
Lymphatic transport of high-density lipoproteins and chylomicrons. J Clin Invest (2014) 1.15
Association between objectively assessed sedentary time and physical activity with metabolic risk factors among people with recently diagnosed type 2 diabetes. Diabetologia (2013) 1.15
The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease. Cell (2016) 1.13
Atherosclerosis: process, indicators, risk factors and new hopes. Int J Prev Med (2014) 1.12
Dysfunctional HDL and atherosclerotic cardiovascular disease. Nat Rev Cardiol (2015) 1.11
Quantification of HDL proteins, cardiac events, and mortality in patients with type 2 diabetes on hemodialysis. Clin J Am Soc Nephrol (2014) 1.10
High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease. J Lipid Res (2013) 1.09
The ABCA1 gene R230C variant is associated with decreased risk of premature coronary artery disease: the genetics of atherosclerotic disease (GEA) study. PLoS One (2012) 1.08
Mendelian randomization in health research: using appropriate genetic variants and avoiding biased estimates. Econ Hum Biol (2013) 1.08
Genes for blood pressure: an opportunity to understand hypertension. Eur Heart J (2013) 1.07
ANGPTL3 blockade with a human monoclonal antibody reduces plasma lipids in dyslipidemic mice and monkeys. J Lipid Res (2015) 1.07
Protein-Truncating Variants at the Cholesteryl Ester Transfer Protein Gene and Risk for Coronary Heart Disease. Circ Res (2017) 1.06
High-density lipoprotein and atherosclerosis regression: evidence from preclinical and clinical studies. Circ Res (2014) 1.04
Methylation at CPT1A locus is associated with lipoprotein subfraction profiles. J Lipid Res (2014) 1.04
An in-silico model of lipoprotein metabolism and kinetics for the evaluation of targets and biomarkers in the reverse cholesterol transport pathway. PLoS Comput Biol (2014) 1.03
Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA. J Lipid Res (2015) 1.03
Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: systematic review and meta-analysis of 14,015 stroke cases and pooled analysis of primary biomarker data from up to 60,883 individuals. Int J Epidemiol (2013) 1.03
Association of Lipid Fractions With Risks for Coronary Artery Disease and Diabetes. JAMA Cardiol (2016) 1.02
Progress and promise in understanding the genetic basis of common diseases. Proc Biol Sci (2015) 1.02
Current perspectives in genetic cardiovascular disorders: from basic to clinical aspects. Heart Vessels (2013) 1.02
HDL cholesterol is not associated with lower mortality in patients with kidney dysfunction. J Am Soc Nephrol (2014) 1.01
Genetic modulation of lipid profiles following lifestyle modification or metformin treatment: the Diabetes Prevention Program. PLoS Genet (2012) 0.99
Using multivariable Mendelian randomization to disentangle the causal effects of lipid fractions. PLoS One (2014) 0.99
Aging affects high-density lipoprotein composition and function. Biochim Biophys Acta (2013) 0.98
The Swedish CArdioPulmonary BioImage Study: objectives and design. J Intern Med (2015) 0.98
Molecules that mimic apolipoprotein A-I: potential agents for treating atherosclerosis. J Med Chem (2013) 0.98
Best (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization studies. Am J Clin Nutr (2016) 0.98
The many weak instruments problem and Mendelian randomization. Stat Med (2014) 0.97
Hyperlipidemia as a risk factor for cardiovascular disease. Prim Care (2012) 0.97
A Mendelian randomization study of the effect of type-2 diabetes on coronary heart disease. Nat Commun (2015) 0.97
APOM and high-density lipoprotein cholesterol are associated with lung function and per cent emphysema. Eur Respir J (2013) 0.97
Regulation of signal transduction by HDL. J Lipid Res (2013) 0.97
Genetic determinant for amino acid metabolites and changes in body weight and insulin resistance in response to weight-loss diets: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial. Circulation (2013) 0.97
Importance of evaluating cell cholesterol influx with efflux in determining the impact of human serum on cholesterol metabolism and atherosclerosis. Arterioscler Thromb Vasc Biol (2013) 0.96
New therapeutic principles in dyslipidaemia: focus on LDL and Lp(a) lowering drugs. Eur Heart J (2013) 0.96
Function and distribution of apolipoprotein A1 in the artery wall are markedly distinct from those in plasma. Circulation (2013) 0.96
Anti-psoriatic therapy recovers high-density lipoprotein composition and function. J Invest Dermatol (2013) 0.96
APOC3, coronary disease, and complexities of Mendelian randomization. Cell Metab (2014) 0.95
HDL and cholesterol: life after the divorce? J Lipid Res (2013) 0.95
Food Consumption and its Impact on Cardiovascular Disease: Importance of Solutions Focused on the Globalized Food System: A Report From the Workshop Convened by the World Heart Federation. J Am Coll Cardiol (2015) 0.95
Mining the human phenome using allelic scores that index biological intermediates. PLoS Genet (2013) 0.94
The mathematical limits of genetic prediction for complex chronic disease. J Epidemiol Community Health (2015) 0.94
Mendelian randomization supports causality between maternal hyperglycemia and epigenetic regulation of leptin gene in newborns. Epigenetics (2015) 0.94
Disease risk factors identified through shared genetic architecture and electronic medical records. Sci Transl Med (2014) 0.94
Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes. Vasc Health Risk Manag (2013) 0.94
PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet (2007) 209.92
Quantifying heterogeneity in a meta-analysis. Stat Med (2002) 83.16
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet (2005) 32.41
Biological, clinical and population relevance of 95 loci for blood lipids. Nature (2010) 28.21
Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet (2008) 25.83
Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med (2006) 23.83
Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet (2008) 20.66
Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med (2007) 18.78
'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol (2003) 16.71
Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med (2011) 15.30
Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet (2007) 15.27
Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med (2011) 13.55
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Major lipids, apolipoproteins, and risk of vascular disease. JAMA (2009) 10.58
Polymorphisms associated with cholesterol and risk of cardiovascular events. N Engl J Med (2008) 9.83
Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med (2008) 9.39
Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med (2009) 6.16
Mendelian randomization: prospects, potentials, and limitations. Int J Epidemiol (2004) 5.07
Safety of anacetrapib in patients with or at high risk for coronary heart disease. N Engl J Med (2010) 4.42
Monogenic hypercholesterolemia: new insights in pathogenesis and treatment. J Clin Invest (2003) 4.42
Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease. JAMA (2008) 4.41
Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk. JAMA (2008) 4.21
Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat Methods Med Res (2011) 2.83
Limits to causal inference based on Mendelian randomization: a comparison with randomized controlled trials. Am J Epidemiol (2006) 2.16
Endothelial lipase is a major determinant of HDL level. J Clin Invest (2003) 2.12
Apolipoprotein E isoforms, serum cholesterol, and cancer. Lancet (1986) 2.05
Loss-of-function variants in endothelial lipase are a cause of elevated HDL cholesterol in humans. J Clin Invest (2009) 1.83
Identification of genetic variants in endothelial lipase in persons with elevated high-density lipoprotein cholesterol. Circulation (2002) 1.72
LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individuals. J Clin Endocrinol Metab (2011) 1.65
Endothelial lipase modulates susceptibility to atherosclerosis in apolipoprotein-E-deficient mice. J Biol Chem (2004) 1.54
How to avoid bias when comparing bone marrow transplantation with chemotherapy. Bone Marrow Transplant (1991) 1.52
Hepatic lipase, genetically elevated high-density lipoprotein, and risk of ischemic cardiovascular disease. J Clin Endocrinol Metab (2008) 1.46
Endothelial lipase modulates HDL but has no effect on atherosclerosis development in apoE-/- and LDLR-/- mice. J Lipid Res (2005) 1.35
A second generation human haplotype map of over 3.1 million SNPs. Nature (2007) 85.39
Finding the missing heritability of complex diseases. Nature (2009) 67.95
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science (2007) 51.70
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science (2007) 43.16
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet (2002) 40.37
Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet (2008) 35.06
Integrating common and rare genetic variation in diverse human populations. Nature (2010) 32.30
A high-resolution recombination map of the human genome. Nat Genet (2002) 28.66
Biological, clinical and population relevance of 95 loci for blood lipids. Nature (2010) 28.21
Genome-wide atlas of gene expression in the adult mouse brain. Nature (2006) 28.02
Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet (2009) 26.09
Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet (2008) 25.83
Genomewide association analysis of coronary artery disease. N Engl J Med (2007) 24.38
Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med (2006) 23.83
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet (2002) 23.18
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08
Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol (2009) 23.08
Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet (2008) 22.35
Genetics of gene expression and its effect on disease. Nature (2008) 21.35
Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet (2008) 20.73
Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet (2008) 20.66
A common allele on chromosome 9 associated with coronary heart disease. Science (2007) 20.37
Large recurrent microdeletions associated with schizophrenia. Nature (2008) 20.25
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01